What does Alzex Neuropharma Inc. do?

Alzex Neuropharma Inc. (TRRI) operates in the Other Precious Metals industry within the Basic Materials sector. Full company description, peers, and segment breakdown are on the page above.

What is TRRI's market cap?

Alzex Neuropharma Inc. (TRRI) has a market capitalization of approximately $602, as of August 25, 2026, based on the most recent share price and shares outstanding.

Does TRRI pay a dividend?

No — Alzex Neuropharma Inc. (TRRI) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

TRRI

Alzex Neuropharma Inc.

OTC·Other Precious Metals · Basic Materials

$0.00$0.00+0.00%

Market cap$602.00·Market closed·Aug 25 8:00 PM UTC

Price Chart

$0.00+$0.00 (+0.00%)today

−80.00%CAGR −27.53%

Select date range

FromTo

Oct 23, 2009Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

TRRI does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

FinancialsFinancials Tab

Revenue$0.00

Net Income−$254.12K

Net Margin—

Operating Cash Flow−$37.94K

Capital Expenditures$0.00

Free Cash Flow−$37.94K

Return on Equity—

Return on Invested Capital18.9%

Net Debt$116.96K

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for TRRI and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how TRRI's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for TRRI and 80,000+ other tickers.

About Alzex Neuropharma Inc.

Trinity Resources Inc. operates as a company specializing in mineral exploration and mining development. It primarily concentrates on projects involving gold, silver, and platinum group metals throughout North and South America. The firm notably possesses interests in the Eureka Placer Claim, which is located in Eureka Creek, California. It was formerly named TruLan Resources Inc. before rebranding as Trinity Resources Inc. in September 2015. The company's principal place of business is in Henderson, Nevada.

CEO: Robert W. Rosner
Sector: Basic Materials
Industry: Other Precious Metals
Exchange: OTC
Employees: 11
Website: trinresinc.com

Peers

Great Panther Mining Ltd

Latest News

News Tab

No recent news available.

Frequently Asked Questions About TRRI

What does Alzex Neuropharma Inc. do?: Alzex Neuropharma Inc. (TRRI) operates in the Other Precious Metals industry within the Basic Materials sector. Full company description, peers, and segment breakdown are on the page above.
What is TRRI's market cap?: Alzex Neuropharma Inc. (TRRI) has a market capitalization of approximately $602, as of August 25, 2026, based on the most recent share price and shares outstanding.
Does TRRI pay a dividend?: No — Alzex Neuropharma Inc. (TRRI) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.